Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study

Fig. 4

Stratified CerMe provided the reference for pathological diagnoses. A Stratification according to the CerMe values. B The proportion of pathology types on colposcopy in CerMe-positive (CerMe +) and CerMe-negative (CerMe −) cases as well as the PPV of CIN2 + in stratified CerMe + cases of the hrHPV-positive cohort. C Distributions of stratified CerMe (negative, weakly positive, moderately positive, and strongly positive) and cytology in colposcopic diagnoses. Bar chart showing the percentage of stratified CerMe cases in colposcopic diagnoses. D The sensitivity of CerMe and cytology testing in the detection of SCC and AC. SCC, squamous cell carcinoma; AC, adenocarcinoma

Back to article page